Oramed Pharmaceuticals (ORMP) Operating Income (2011 - 2026)
Oramed Pharmaceuticals (ORMP) posted Operating Income of -$3.7 million for Q1 2026, up 35.49% on a QoQ basis from -$5.7 million in Q4 2025, and up 18.69% year-over-year from -$3.1 million in Q1 2025.
Oramed Pharmaceuticals (ORMP) Operating Income (2011 - 2026) Analysis & Trends
Oramed Pharmaceuticals' Operating Income history runs 15 years deep, the most recent figure standing at -$3.7 million for Q1 2026.
- Quarterly Operating Income rose 18.69% year-over-year to -$3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$14.2 million (up 0.5% YoY) and the FY2025 annual result came in at -$15.1 million, down 18.05% from the prior year.
- Operating Income was -$3.7 million for Q1 2026 at Oramed Pharmaceuticals, up from -$5.7 million in the prior quarter.
- Across five years, Operating Income topped out at -$2.4 million in Q3 2025 and bottomed at -$12.3 million in Q4 2022.
- A 5-year average of -$5.3 million and a median of -$3.8 million in 2023 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2023 — Operating Income jumped 68.55% — and 2025, when it sank 57.77%.
- Oramed Pharmaceuticals' Operating Income stood at -$12.3 million in 2022, then soared by 68.55% to -$3.9 million in 2023, then climbed by 7.27% to -$3.6 million in 2024, then sank by 57.77% to -$5.7 million in 2025, then jumped by 35.49% to -$3.7 million in 2026.
- Business Quant data shows ORMP's Operating Income at -$3.7 million in Q1 2026, -$5.7 million in Q4 2025, and -$2.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - | -3.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.66 Mn |
| Dec 31, 2025 | -5.67 Mn |
| Sep 30, 2025 | -2.43 Mn |
| Jun 30, 2025 | -2.49 Mn |
| Mar 31, 2025 | -4.50 Mn |
| Dec 31, 2024 | -3.60 Mn |
| Sep 30, 2024 | -3.09 Mn |
| Jun 30, 2024 | -3.14 Mn |
| Mar 31, 2024 | -2.96 Mn |
| Dec 31, 2023 | -3.88 Mn |
| Sep 30, 2023 | -2.89 Mn |
| Jun 30, 2023 | -3.79 Mn |
| Mar 31, 2023 | -5.21 Mn |
| Dec 31, 2022 | -12.33 Mn |
| Sep 30, 2022 | -8.19 Mn |
| Jun 30, 2022 | -11.42 Mn |
| Mar 31, 2022 | -11.25 Mn |
| Aug 31, 2021 | -24.22 Mn |
| Nov 30, 2019 | -2.43 Mn |
| Aug 31, 2019 | -2.35 Mn |